News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IMPAX Laboratories, Inc. (IPXL) Launches Generic Solaraze® (Diclofenac Sodium Gel, 3%)


11/21/2013 11:30:07 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it is commencing shipment of generic Solaraze® (diclofenac sodium gel, 3%), a first-to-file product, through Global Pharmaceuticals, Impax’s generics division.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES